Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
-
4181
-
4182
-
4183
-
4184
-
4185
-
4186
-
4187
-
4188
-
4189
-
4190
-
4191
Synthesis and Characterization of <i>meso</i>-Triarylsubporphyrins
Published 2007“…The synthesis of several <i>meso</i>-triaryl-subporphyrins, based on utilizing tripyrrolylborane as a precursor in a reaction with arylaldehydes (where aryl = phenyl, 4- and 3-pyridyl, tolyl, 4-methoxyphenyl, and 4-(trifluoromethyl)phenyl) under reflux in propionic acid, is reported. …”
-
4192
Synthesis and Characterization of <i>meso</i>-Triarylsubporphyrins
Published 2007“…The synthesis of several <i>meso</i>-triaryl-subporphyrins, based on utilizing tripyrrolylborane as a precursor in a reaction with arylaldehydes (where aryl = phenyl, 4- and 3-pyridyl, tolyl, 4-methoxyphenyl, and 4-(trifluoromethyl)phenyl) under reflux in propionic acid, is reported. …”
-
4193
MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
Published 2017“…</p><p>Methods</p><p>We constructed a dynamic transmission model of an MDR-TB epidemic in an illustrative East/Southeast Asian setting. …”
-
4194
-
4195
-
4196
-
4197
-
4198
-
4199
hMSC adjunctive therapy failed to decrease pulmonary inflammation or prevent ALI compared to antiviral therapy alone in experimental severe influenza.
Published 2013“…<p>Eight-week old male C57Bl/6 mice infected with 425 EID<sub>50</sub> influenza A/PR/8 virus were administered 2.5 mg/kg oseltamivir in 100 ul ddH2O via gavage, 1×daily for 5 days, beginning day 2 P.I., with or without hMSC administration (5×10<sup>5</sup> cells) on day 2 P.I. and sacrificed on day 7 P.I. …”
-
4200